Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Coser (1958)
Authority and Decision-Making in a Hospital: A Comparative AnalysisAmerican Sociological Review, 23
Feigin RD (1987)
Textbook of Pediatric Infectious Disease
J. Lomas, G. Anderson, K. Domnick-Pierre, E. Vayda, M. Enkin, W. Hannah (1989)
Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians.The New England journal of medicine, 321 19
Centers for Disease Control (1991)
Recommendations and ReportsMMWR, 40
Anderson GM Lomas J (1989)
Do practice guidelines guide practice?N Engl J Med., 321
James Coleman, Herbert Menzel, Elihu Katz (1959)
Social processes in physicians' adoption of a new drug.Journal of chronic diseases, 9 1
DiFrancesco E (1990)
Manufacturer requests lower age for Hib immunizationInfect Dis Child., 3
M. Becker, P. Stolley, L. Lasagna, J. McEvilla, L. Sloane (1972)
Differential education concerning therapeutics and resultant physician prescribing patterns.Journal of medical education, 47 2
R. Bauer, Lawrence Wortzel (1966)
Doctor's Choice: The Physician and his Sources of Information about DrugsJournal of Marketing Research, 3
H. Menzel, E. Katz (1955)
Social Relations and Innovation in the Medical Profession: The Epidemiology of a New DrugPublic Opinion Quarterly, 19
I. Ulus, R. Wurtman (1988)
Prevention by choline of the depletion of membrane phosphatidylcholine by a cholinesterase inhibitor.The New England journal of medicine, 318 3
Pedroni AT Wilde JA (1991)
Your liability for vaccine-related injuriesContemp Pediatr., 8
Williamson PM (1975)
The adoption of new drugs by doctors practicing in group and solo practiceSoc Sci Med., 9
S. Cochi, C. Broome, A. Hightower (1985)
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.JAMA, 253 4
(1990)
HHS News
C. Broome (1987)
Epidemiology of Haemophilus influenzae type b infections in the United States.The Pediatric infectious disease journal, 6 8
Abstract Sir.—Haemophilus influenzae type b (Hib) infection in children is responsible for approximately 12 000 cases of meningitis and 7500 cases of other invasive diseases annually in the United States,1,2 with a mortality rate of 5% in cases of meningitis and as many as 40% of survivors having significant neurologic sequelae.3 On October 4, 1990, the Food and Drug Administration (FDA) permitted one Hib vaccine manufacturer to amend its package insert to claim safety and efficacy for administration at age 2 months.4 The previous recommended age of first administration had been 15 months. The American Academy of Pediatrics (AAP) soon issued a recommendation for first administration to infants at age 2 months. A letter called a Ped-Comm was sent from the AAP to its members in late October 1990 recommending the earlier age for first vaccination, but information on safety or efficacy was not included since References 1. Cochi SL, Broome CV, Hightower AW. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine: a cost-effectiveness model of strategy assessment . JAMA . 1985:253:521-529.Crossref 2. Broome CV. Epidemiology of Haemophilus influenzae, type b infections in the United States . Pediatr Infect Dis J. 1987;6:779-782.Crossref 3. Feigin RD. Bacterial meningitis beyond the neonatal period . In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Disease . Philadelphia, Pa: WB Saunders Co; 1987:439-477. 4. HHS News . Washington, DC: US Dept of Health and Human Services; (October 4) ,1990:1-3. 5. Centers for Disease Control. Recommendations and Reports . MMWR . 1991;40( (RR) -1):1-7. 6. DiFrancesco E. Manufacturer requests lower age for Hib immunization . Infect Dis Child. 1990;3:10-11. 7. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? N Engl J Med. 1989; 321:1306-1311.Crossref 8. Wilde JA, Pedroni AT. Your liability for vaccine-related injuries . Contemp Pediatr. 1991; 8:51-54. 9. Bauer RA, Wortzel LH. Doctor's choice: the physician and his sources of information about drugs . J Marketing Res. 1966;3:40-47.Crossref 10. Menzel H, Katz E. Social relations and innovation in the medical profession: the epidemiology of a new drug . Public Opinion Q. Winter 1956;19:337-352.Crossref 11. Coleman J, Menzel H, Katz E. Social processes in physicians' adoption of a new drug . J Chronic Dis. 1959;9:1-19.Crossref 12. Williamson PM. The adoption of new drugs by doctors practicing in group and solo practice . Soc Sci Med. 1975;9:233-236.Crossref 13. Becker MH, Stoley PD, Lasagna L. Differential education concerning therapeutics and resultant physician prescribing patterns . J Med Educ. 1972;47:118-127. 14. Coser RL. Authority and decision making in a hospital: a comparative analysis . Am Sociol Rev. 1958;23:56-64.Crossref
American Journal of Diseases of Children – American Medical Association
Published: Feb 1, 1993
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.